Recent News Headlines : Acute Lymphoblastic Leukemia

PHARMACEUTICAL GIANT PLANNED TO DESTROY STOCKS OF CANCER DRUGS TO FORCE PRICE HIKE - REPORT


However, it was not an isolated example of such aggressive policy as Aspen also actively tried to impose higher prices on its cancer drugs throughout Europe... READ MORE

15th April, 2017 2137

RECORDED CHILDHOOD CANCERS RISE BY 13% WORLDWIDE, STUDY FINDS


In poorer countries, some children's cancers are never diagnosed and their deaths will not be investigated... READ MORE

12th April, 2017 1456

ROCHE, BRISTOL-MYERS CUT CANCER DRUG PRICES TO WIN UK APPROVAL


Bristol's leukemia drug Sprycel was also recommended for routine use after the U.S. company offered a bigger discount... READ MORE

17th November, 2016 343


IMPORTANT TERMS OF USE & DISCLAIMER INFORMATION:

Daily Digital News provides public access to an archive of historical news articles from many popular news sources. Daily Digital News provides keyword searchable summaries, and links, to news articles that were originally publically accessible, and all news articles presented on dailydigitalnews.com were initially freely available to the general public. Daily Digital News does not claim any copyright ownership of the aggregated content of this website. Aggregated news content presented on dailydigitalnews.com may be subject to copyright, and the use made here is consistent with the principles of limited use for research and education. Daily Digital News takes advantage of unique web-crawling technologies and algorithms. This includes the use of services provided by Alchemy API (by IBM Watson) as well as other open source technologies. Daily Digital News operates this website on a not for profit basis. No income, revenue, remuneration, or profit of any kind has been made as a result of providing this website to the public. Use of this website is at the user's own discretion. Daily Digital News exercises no control over the use made of this website and accepts no liability to users or resources in relation to the contents of, or use of, or otherwise in connection with this website. Full Terms & Conditions